We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Structure of primary cannabinoid receptor is revealed
News

Structure of primary cannabinoid receptor is revealed

Structure of primary cannabinoid receptor is revealed
News

Structure of primary cannabinoid receptor is revealed

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Structure of primary cannabinoid receptor is revealed "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

New research is providing a more detailed view into the structure of the human cannabinoid (CB1) receptor. These findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol (THC)—a primary chemical in marijuana—bind at the CB1 receptor to produce their effects. The research was funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).


See Also: Previously unknown function of cannabinoid receptor discovered


There is considerable interest in the possible therapeutic uses of marijuana and its constituent cannabinoid compounds. Molecules that target CB1 receptors may have promise in treating a variety of conditions such as pain, inflammation, obesity, nerve cell diseases, and substance use disorders. However, some synthetic cannabinoids such as K2 or Spice can produce severe and even deadly reactions, whereas other cannabinoids produce less serious side effects.


"Cannabinoids can produce very different outcomes, depending on how they bind to the CB1 receptor," said NIDA Director Nora Volkow, MD "Understanding how these chemicals bind to the CB1 receptor will help guide the design of new medications and provide insight into the therapeutic promise of the body's cannabinoid system."


Don't Miss: Blocking brain’s endocannabinoids may trigger early Alzheimer’s deficits, study shows


Researchers used a specific chemical, AM6538, to inactivate and crystallize the CB1 receptor. They then computed the three-dimensional structure of the CB1-AM6538 complex through crystallography, which determines molecular shape by measuring the angles and intensities of X-rays that are bounced off a crystal structure. Based upon prior evidence showing how specific cannabinoids attach to different chemical configurations, researchers were able predict how these cannabinoids would fit into the three-dimensional CB1 model. The model was also used to calculate how long each cannabinoid bound to the CB1 receptor, thereby providing clues into mechanisms whereby some chemicals produce longer-lasting effects.


Read Next: Exercise can increase levels of hunger-promoting endocannabinoids even if you are sleep-deprived


"We found that the CB1 receptor consists of multiple sub-pockets and channels," said Alexandros Makriyannis, PhD, director of the Center for Drug Discovery, Northeastern University in Boston, and a co-author on the paper. "This complex structure will allow chemists to design diverse compounds that specifically target portions of the receptor to produce desired effects."


Note: Material may have been edited for length and content. For further information, please contact the cited source.


NIH/National Institute on Drug Abuse   press release


Publication

Hua T et al. Crystal Structure of the Human Cannabinoid Receptor CB1.  Cell, Published October 20 2016. doi: 10.1016/j.cell.2016.10.004


Advertisement